产品: VCAN 抗体
货号: DF10007
描述: Rabbit polyclonal antibody to VCAN
应用: WB IHC
反应: Human
预测: Bovine, Sheep, Rabbit, Dog, Chicken, Xenopus
分子量: 373 kDa; 373kD(Calculated).
蛋白号: P13611
RRID: AB_2840587

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:1000-3000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human
预测:
Bovine(91%), Sheep(91%), Rabbit(100%), Dog(100%), Chicken(100%), Xenopus(100%)
克隆:
Polyclonal
特异性:
VCAN Antibody detects endogenous levels of total VCAN.
RRID:
AB_2840587
引用格式: Affinity Biosciences Cat# DF10007, RRID:AB_2840587.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

Chondroitin sulfate proteoglycan 2; Chondroitin sulfate proteoglycan core protein 2; Chondroitin sulfate proteoglycan core protein, cartilage; CSPG2; CSPG2_HUMAN; ERVR; GHAP; Glial hyaluronate binding protein; Glial hyaluronate-binding protein; Large fibroblast proteoglycan; PG-M; PGM; VCAN; Versican; Versican core protein; Versican proteoglycan; WGN 1; WGN; WGN1;

抗原和靶标

免疫原:
Uniprot:
基因/基因ID:
表达:
P13611 CSPG2_HUMAN:

Expressed in the retina (at protein level) (PubMed:29777959). Cerebral white matter and plasma (PubMed:2469524). Isoform V0: Expressed in normal brain, gliomas, medulloblastomas, schwannomas, neurofibromas, and meningiomas (PubMed:8627343). Isoform V1: Expressed in normal brain, gliomas, medulloblastomas, schwannomas, neurofibromas, and meningiomas (PubMed:8627343). Isoform V2: Restricted to normal brain and gliomas (PubMed:8627343). Isoform V3: Found in all these tissues except medulloblastomas (PubMed:8627343).

序列:
MFINIKSILWMCSTLIVTHALHKVKVGKSPPVRGSLSGKVSLPCHFSTMPTLPPSYNTSEFLRIKWSKIEVDKNGKDLKETTVLVAQNGNIKIGQDYKGRVSVPTHPEAVGDASLTVVKLLASDAGLYRCDVMYGIEDTQDTVSLTVDGVVFHYRAATSRYTLNFEAAQKACLDVGAVIATPEQLFAAYEDGFEQCDAGWLADQTVRYPIRAPRVGCYGDKMGKAGVRTYGFRSPQETYDVYCYVDHLDGDVFHLTVPSKFTFEEAAKECENQDARLATVGELQAAWRNGFDQCDYGWLSDASVRHPVTVARAQCGGGLLGVRTLYRFENQTGFPPPDSRFDAYCFKPKEATTIDLSILAETASPSLSKEPQMVSDRTTPIIPLVDELPVIPTEFPPVGNIVSFEQKATVQPQAITDSLATKLPTPTGSTKKPWDMDDYSPSASGPLGKLDISEIKEEVLQSTTGVSHYATDSWDGVVEDKQTQESVTQIEQIEVGPLVTSMEILKHIPSKEFPVTETPLVTARMILESKTEKKMVSTVSELVTTGHYGFTLGEEDDEDRTLTVGSDESTLIFDQIPEVITVSKTSEDTIHTHLEDLESVSASTTVSPLIMPDNNGSSMDDWEERQTSGRITEEFLGKYLSTTPFPSQHRTEIELFPYSGDKILVEGISTVIYPSLQTEMTHRRERTETLIPEMRTDTYTDEIQEEITKSPFMGKTEEEVFSGMKLSTSLSEPIHVTESSVEMTKSFDFPTLITKLSAEPTEVRDMEEDFTATPGTTKYDENITTVLLAHGTLSVEAATVSKWSWDEDNTTSKPLESTEPSASSKLPPALLTTVGMNGKDKDIPSFTEDGADEFTLIPDSTQKQLEEVTDEDIAAHGKFTIRFQPTTSTGIAEKSTLRDSTTEEKVPPITSTEGQVYATMEGSALGEVEDVDLSKPVSTVPQFAHTSEVEGLAFVSYSSTQEPTTYVDSSHTIPLSVIPKTDWGVLVPSVPSEDEVLGEPSQDILVIDQTRLEATISPETMRTTKITEGTTQEEFPWKEQTAEKPVPALSSTAWTPKEAVTPLDEQEGDGSAYTVSEDELLTGSERVPVLETTPVGKIDHSVSYPPGAVTEHKVKTDEVVTLTPRIGPKVSLSPGPEQKYETEGSSTTGFTSSLSPFSTHITQLMEETTTEKTSLEDIDLGSGLFEKPKATELIEFSTIKVTVPSDITTAFSSVDRLHTTSAFKPSSAITKKPPLIDREPGEETTSDMVIIGESTSHVPPTTLEDIVAKETETDIDREYFTTSSPPATQPTRPPTVEDKEAFGPQALSTPQPPASTKFHPDINVYIIEVRENKTGRMSDLSVIGHPIDSESKEDEPCSEETDPVHDLMAEILPEFPDIIEIDLYHSEENEEEEEECANATDVTTTPSVQYINGKHLVTTVPKDPEAAEARRGQFESVAPSQNFSDSSESDTHPFVIAKTELSTAVQPNESTETTESLEVTWKPETYPETSEHFSGGEPDVFPTVPFHEEFESGTAKKGAESVTERDTEVGHQAHEHTEPVSLFPEESSGEIAIDQESQKIAFARATEVTFGEEVEKSTSVTYTPTIVPSSASAYVSEEEAVTLIGNPWPDDLLSTKESWVEATPRQVVELSGSSSIPITEGSGEAEEDEDTMFTMVTDLSQRNTTDTLITLDTSRIITESFFEVPATTIYPVSEQPSAKVVPTKFVSETDTSEWISSTTVEEKKRKEEEGTTGTASTFEVYSSTQRSDQLILPFELESPNVATSSDSGTRKSFMSLTTPTQSEREMTDSTPVFTETNTLENLGAQTTEHSSIHQPGVQEGLTTLPRSPASVFMEQGSGEAAADPETTTVSSFSLNVEYAIQAEKEVAGTLSPHVETTFSTEPTGLVLSTVMDRVVAENITQTSREIVISERLGEPNYGAEIRGFSTGFPLEEDFSGDFREYSTVSHPIAKEETVMMEGSGDAAFRDTQTSPSTVPTSVHISHISDSEGPSSTMVSTSAFPWEEFTSSAEGSGEQLVTVSSSVVPVLPSAVQKFSGTASSIIDEGLGEVGTVNEIDRRSTILPTAEVEGTKAPVEKEEVKVSGTVSTNFPQTIEPAKLWSRQEVNPVRQEIESETTSEEQIQEEKSFESPQNSPATEQTIFDSQTFTETELKTTDYSVLTTKKTYSDDKEMKEEDTSLVNMSTPDPDANGLESYTTLPEATEKSHFFLATALVTESIPAEHVVTDSPIKKEESTKHFPKGMRPTIQESDTELLFSGLGSGEEVLPTLPTESVNFTEVEQINNTLYPHTSQVESTSSDKIEDFNRMENVAKEVGPLVSQTDIFEGSGSVTSTTLIEILSDTGAEGPTVAPLPFSTDIGHPQNQTVRWAEEIQTSRPQTITEQDSNKNSSTAEINETTTSSTDFLARAYGFEMAKEFVTSAPKPSDLYYEPSGEGSGEVDIVDSFHTSATTQATRQESSTTFVSDGSLEKHPEVPSAKAVTADGFPTVSVMLPLHSEQNKSSPDPTSTLSNTVSYERSTDGSFQDRFREFEDSTLKPNRKKPTENIIIDLDKEDKDLILTITESTILEILPELTSDKNTIIDIDHTKPVYEDILGMQTDIDTEVPSEPHDSNDESNDDSTQVQEIYEAAVNLSLTEETFEGSADVLASYTQATHDESMTYEDRSQLDHMGFHFTTGIPAPSTETELDVLLPTATSLPIPRKSATVIPEIEGIKAEAKALDDMFESSTLSDGQAIADQSEIIPTLGQFERTQEEYEDKKHAGPSFQPEFSSGAEEALVDHTPYLSIATTHLMDQSVTEVPDVMEGSNPPYYTDTTLAVSTFAKLSSQTPSSPLTIYSGSEASGHTEIPQPSALPGIDVGSSVMSPQDSFKEIHVNIEATFKPSSEEYLHITEPPSLSPDTKLEPSEDDGKPELLEEMEASPTELIAVEGTEILQDFQNKTDGQVSGEAIKMFPTIKTPEAGTVITTADEIELEGATQWPHSTSASATYGVEAGVVPWLSPQTSERPTLSSSPEINPETQAALIRGQDSTIAASEQQVAARILDSNDQATVNPVEFNTEVATPPFSLLETSNETDFLIGINEESVEGTAIYLPGPDRCKMNPCLNGGTCYPTETSYVCTCVPGYSGDQCELDFDECHSNPCRNGATCVDGFNTFRCLCLPSYVGALCEQDTETCDYGWHKFQGQCYKYFAHRRTWDAAERECRLQGAHLTSILSHEEQMFVNRVGHDYQWIGLNDKMFEHDFRWTDGSTLQYENWRPNQPDSFFSAGEDCVVIIWHENGQWNDVPCNYHLTYTCKKGTVACGQPPVVENAKTFGKMKPRYEINSLIRYHCKDGFIQRHLPTIRCLGNGRWAIPKITCMNPSAYQRTYSMKYFKNSSSAKDNSINTSKHDHRWSRRWQESRR

种属预测

种属预测:

score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。

Species
Results
Score
Dog
100
Xenopus
100
Chicken
100
Rabbit
100
Bovine
91
Sheep
91
Pig
0
Horse
0
Zebrafish
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

翻译修饰 - P13611 作为底物

Site PTM Type Enzyme
K68 Acetylation
K79 Acetylation
K98 Acetylation
K98 Ubiquitination
Y208 Phosphorylation
S364 Phosphorylation
S368 Phosphorylation
S510 O-Glycosylation
T516 O-Glycosylation
T518 O-Glycosylation
T522 O-Glycosylation
T627 O-Glycosylation
T632 O-Glycosylation
S641 O-Glycosylation
T642 O-Glycosylation
T642 Phosphorylation
T643 O-Glycosylation
S647 Phosphorylation
T687 O-Glycosylation
T689 O-Glycosylation
T716 O-Glycosylation
T716 Phosphorylation
S727 Phosphorylation
T751 O-Glycosylation
T754 O-Glycosylation
T792 O-Glycosylation
T799 O-Glycosylation
S801 O-Glycosylation
T869 O-Glycosylation
T886 O-Glycosylation
T887 O-Glycosylation
S888 O-Glycosylation
T889 O-Glycosylation
S976 O-Glycosylation
T981 O-Glycosylation
T1092 O-Glycosylation
T1093 O-Glycosylation
S1101 O-Glycosylation
S1103 O-Glycosylation
T1110 O-Glycosylation
T1116 O-Glycosylation
T1121 O-Glycosylation
T1123 O-Glycosylation
S1131 O-Glycosylation
S1133 O-Glycosylation
T1191 O-Glycosylation
S1212 O-Glycosylation
T1219 O-Glycosylation
T1220 O-Glycosylation
S1221 O-Glycosylation
S1349 Phosphorylation
S1351 Phosphorylation
T1418 O-Glycosylation
T1419 O-Glycosylation
T1566 O-Glycosylation
T1569 O-Glycosylation
S1716 O-Glycosylation
T1719 O-Glycosylation
T1731 O-Glycosylation
T1734 O-Glycosylation
S1742 O-Glycosylation
S1743 O-Glycosylation
T1744 O-Glycosylation
T1763 O-Glycosylation
S1765 O-Glycosylation
T1769 O-Glycosylation
S1772 O-Glycosylation
S1775 O-Glycosylation
T1777 O-Glycosylation
T1778 O-Glycosylation
T1780 O-Glycosylation
S1909 O-Glycosylation
S1925 O-Glycosylation
T1926 O-Glycosylation
S1935 O-Glycosylation
S1942 O-Glycosylation
T1943 O-Glycosylation
S1945 O-Glycosylation
T2036 O-Glycosylation
T2050 Phosphorylation
S2058 O-Glycosylation
S2058 Phosphorylation
T2059 O-Glycosylation
T2059 Phosphorylation
T2063 O-Glycosylation
T2069 O-Glycosylation
T2083 O-Glycosylation
S2085 O-Glycosylation
T2086 O-Glycosylation
T2086 Phosphorylation
T2091 O-Glycosylation
S2099 Phosphorylation
T2115 Phosphorylation
S2116 Phosphorylation
T2152 O-Glycosylation
T2153 O-Glycosylation
T2159 O-Glycosylation
T2160 O-Glycosylation
T2163 Phosphorylation
T2194 O-Glycosylation
T2200 O-Glycosylation
S2203 O-Glycosylation
K2238 Methylation
T2331 Phosphorylation
S2337 Phosphorylation
T2416 O-Glycosylation
S2417 O-Glycosylation
S2422 O-Glycosylation
T2448 O-Glycosylation
S2455 O-Glycosylation
S2456 O-Glycosylation
T2457 O-Glycosylation
T2458 O-Glycosylation
S2473 O-Glycosylation
T2503 O-Glycosylation
T2505 O-Glycosylation
T2509 O-Glycosylation
S2515 O-Glycosylation
T2516 O-Glycosylation
S2530 O-Glycosylation
T2531 O-Glycosylation
T2540 O-Glycosylation
T2617 Phosphorylation
T2656 O-Glycosylation
S2661 O-Glycosylation
S2699 O-Glycosylation
T2701 O-Glycosylation
S2781 O-Glycosylation
T2784 O-Glycosylation
T2785 O-Glycosylation
S2941 Phosphorylation
T2950 O-Glycosylation
S3024 O-Glycosylation
T3025 O-Glycosylation
S3029 O-Glycosylation
T3205 Phosphorylation
S3206 Phosphorylation
S3209 Phosphorylation
K3312 Acetylation
S3363 Phosphorylation

研究背景

功能:

May play a role in intercellular signaling and in connecting cells with the extracellular matrix. May take part in the regulation of cell motility, growth and differentiation. Binds hyaluronic acid.

翻译修饰:

Phosphorylated by FAM20C in the extracellular medium.

细胞定位:

Secreted>Extracellular space>Extracellular matrix. Cell projection>Cilium>Photoreceptor outer segment. Secreted>Extracellular space>Extracellular matrix>Interphotoreceptor matrix.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
组织特异性:

Expressed in the retina (at protein level). Cerebral white matter and plasma. Isoform V0: Expressed in normal brain, gliomas, medulloblastomas, schwannomas, neurofibromas, and meningiomas. Isoform V1: Expressed in normal brain, gliomas, medulloblastomas, schwannomas, neurofibromas, and meningiomas. Isoform V2: Restricted to normal brain and gliomas. Isoform V3: Found in all these tissues except medulloblastomas.

亚基结构:

Interacts with FBLN1.

蛋白家族:

Belongs to the aggrecan/versican proteoglycan family.

研究领域

· Environmental Information Processing > Signaling molecules and interaction > Cell adhesion molecules (CAMs).   (View pathway)

文献引用

1). Establishment and functional characterization of immortalized rabbit dermal papilla cell lines. Animal biotechnology, 2023 (PubMed: 37652434) [IF=3.7]

Application: IF/ICC    Species: rabbit    Sample: DPCs and R-7 cell

Figure 2. Indirect immunofluorescence staining of primary DPCs and R-7. All the DPCs were incubated with antibodies against α-SMA, SV40LT and Versican (Scale Bar: 50 µm). Passage 5 of DPCs were used.

2). miR-543 impairs cell proliferation, migration, and invasion in breast cancer by suppressing VCAN. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021 (PubMed: 34293593) [IF=3.1]

Application: WB    Species: Human    Sample: BC cell

Fig. 4. The low expression of VCAN blocked BC cell malignancy caused by miR-543 inhibitor. (A) VCAN protein levels in MDA-MB-231 and MCF-7 treated with si-VCAN þ miR- 543 inhibitor, miR-543 inhibitor, si-VCAN, inhibitor-NC and si-NC were detected by western blotting. (B) Cell viability of MDA-MB-231 and MCF-7 treated with si-VCAN þ miR-543 inhibitor, miR-543 inhibitor, si-VCAN, inhibitor-NC and si-NC were detected by CCK-8 assay. (C) Cell proliferation of MDA-MB-231 and MCF-7 treated with si-VCAN þ miR-543 inhibitor, miR-543 inhibitor, si-VCAN, inhibitor-NC and si-NC were detected by BrdU assay. (D) Cell migration of MDA-MB-231 and MCF-7 treated with si-VCAN þ miR-543 inhibitor, miR-543 inhibitor, si-VCAN, inhibitor-NC and si-NC was detected by wound healing assay. (E) Cell invasion of MDA-MB-231 and MCF-7 treated with si-VCAN þ miR-543 inhibitor, miR-543 inhibitor, si-VCAN, inhibitor-NC and si-NC was detected by transwell assay. *P < 0.05, **P < 0.001 versus negative control group. #P < 0.05, ##P < 0.001 versus si- VCAN þ miR-543 inhibitor. Data are presented as the mean ± SD.

3). Exosomes Derived from Dermal Papilla Cells Mediate Hair Follicle Stem Cell Proliferation through the Wnt3a/β-Catenin Signaling Pathway. Oxidative Medicine and Cellular Longevity, 2022 (PubMed: 36388171)

Application: IF/ICC    Species: Mouse    Sample:

Figure 1 Morphology and indirect immunofluorescence staining of HFSCs and DPCs. (a) α-SMA and Versican antibodies were incubated with DPCs (passage 2) (scale bar: 50 μm). (b) Alkaline phosphatase staining was examined with DPCs (passage 8) (scale bar: 100 μm, 50 μm). (c) KRT14, KRT15, and KRT19 antibodies were incubated with HFSCs (passage 2) (scale bar: 50 μm).

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.